Highbury Group

What Highbury Group does

Highbury Group is a privately held, founder-operated venture capital and advisory practice based in Seattle, founded in 2014 and led by Ling Wong. The firm operates an integrated three-pillar model: Invest, providing concentrated equity positions in frontier companies with fewer cheques than typical venture firms; Advise, offering board and founder counsel at inflection points such as new markets, new capital, and new scale; and Build, co-creating alongside operators from initial concept through first revenue, with Highbury capital and conviction. Deal flow and client engagement are generated through direct founder, board, and co-investor outreach, with a stated commitment that every inbound message is read and answered personally.

The practice's publicly disclosed portfolio spans precision oncology (Guardant Health), healthcare delivery (Devoted), longevity therapeutics (BioAge), diagnostics (Visby Medical), skin health (Evme), payments infrastructure (Stripe), and productivity software (Notion) — reflecting deliberate diversification across sectors and sciences rather than thematic concentration. The differentiated selling proposition is concentrated ownership and long-term partnership combined with scientific-technical credibility derived from Ling Wong's PhD (Harvard), BS in Chemical Engineering & Biology (MIT), and inventor credentials (Inhaled Vaccine).

Business model mechanics — fund size, management fee economics, advisory pricing, and carried-interest realizations — are not disclosed. GTM is network-mediated: minimal marketing presence, a single-firm website, a LinkedIn presence for the founder, and a personal-email channel for inbound. Customer concentration at the LP or portfolio-engagement level cannot be assessed from the available data.

Name

Highbury Group

Legal name

Highbury Group

Website

https://highburygrp.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Highbury Group is a Seattle-based, founder-led venture capital and advisory practice that takes concentrated equity positions in frontier companies and provides board-level advisory and co-creation services. Its disclosed portfolio spans healthcare, diagnostics, longevity, payments infrastructure, and productivity software.

Ownership category

akta.pro rank

Product category

Venture Capital and Advisory Services

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Finance & Capital Advisory (BPAHADAB)

akta.pro secondary industry

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)

Keywords

• Venture capital investing
• Startup advisory services
• Founder partnership capital
• Frontier technology backing
• Board advisory counsel

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Marketing channels2 records

Core offering

Highbury Group is a venture capital and investment practice that invests in, advises, and co-builds frontier technology and science-driven companies. It writes concentrated, long-term capital checks, provides board and founder advisory at inflection points, and co-creates alongside operators from whiteboard to first revenue.

Product overview

Highbury Group is a venture capital and investment firm offering three integrated services: Invest (concentrated positions in frontier companies), Advise (board and founder advisory counsel at inflection points), and Build (co-creation from whiteboard to first revenue). The firm maintains a diversified portfolio spanning healthcare (Guardant in precision oncology, Devoted in health, BioAge in longevity therapeutics), technology infrastructure (Stripe), software (Notion), diagnostics (Visby Medical), and skin health (Evme).

Differentiator

Problem solved

Functional benefit

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights3 records

Direct peers

• Lux Capital: Frontier-science venture firm investing in biotech, health, and deep tech — closely comparable to Highbury's healthcare- and frontier-leaning thesis, with similar founder-led scientific credibility.
• Founders Fund: Frontier-tech focused venture firm backing ambitious, often contrarian founders — shares Highbury's orientation toward 'frontier' companies and conviction-driven, concentrated investing posture.
• ARCH Venture Partners: Long-tenured venture firm focused on early-stage science and biotech — directly comparable to Highbury's exposure to BioAge, Visby, and Guardant-style frontier healthcare bets.
• Cantos: Small, thesis-driven venture firm focused on frontier science and deep tech — comparable in scale ethos and conviction-based concentrated investing to Highbury.
• Section32: Venture firm investing in healthcare, biotech, and frontier technology — closely comparable to Highbury's healthcare-tilted portfolio and science-led investment approach.

Broad incumbents

• Khosla Ventures: Large frontier-tech and biotech investor with a founder-led, high-conviction style — overlaps with Highbury's 'invest in hard problems' framing while operating at significantly greater scale and breadth.
• Andreessen Horowitz (a16z): Large, thesis-driven venture firm with dedicated bio/health funds — operates at much greater scale but shares Highbury's frontier, founder-partner orientation and offers overlap in Notion/Stripe-era portfolio DNA.

Emerging players

• Fifty Years: Early-stage fund backing founders solving the world's most important problems — overlaps with Highbury's frontier, mission-driven, concentrated thesis at a comparable emerging-manager scale.
• KdT Ventures: Early-stage fund investing at the intersection of tech and biology — comparable to Highbury's portfolio tilt toward diagnostics, biotech, and deep-tech frontier companies.

Others

• Allen & Company: Boutique private investment and advisory firm offering strategic counsel alongside capital — comparable to Highbury's combined Invest/Advise/Build model and Seattle-adjacent founder-of-innovation heritage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/in/lingwong1

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments7 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Highbury Group